Desh Rakshak Aushdhalaya Ltd vs Kabra Drugs Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 06, 2026

Key Highlights

The Latest Trading Price of Desh Rakshak Aushdhalaya Ltd is ₹ 24.8 as of 06 May 15:30 . The P/E Ratio of Desh Rakshak Aushdhalaya Ltd changed from 4.5 on March 2021 to 29.5 on March 2025 . This represents a CAGR of 45.65% over 5 yearsThe P/E Ratio of Kabra Drugs Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 years The Market Cap of Desh Rakshak Aushdhalaya Ltd changed from ₹ 1.82 crore on March 2021 to ₹ 13.38 crore on March 2025 . This represents a CAGR of 49.03% over 5 yearsThe Market Cap of Kabra Drugs Ltd changed from ₹ 2 crore on March 2022 to ₹ 26.27 crore on March 2025 . This represents a CAGR of 90.37% over 4 years The revenue of Desh Rakshak Aushdhalaya Ltd for the Dec '25 is ₹ 1.4 crore as compare to the Sep '25 revenue of ₹ 0.95 crore. This represent the growth of 47.37% The revenue of Kabra Drugs Ltd for the Dec '25 is ₹ 30.6 crore as compare to the Sep '25 revenue of ₹ 19.94 crore. This represent the growth of 53.46% The ebitda of Desh Rakshak Aushdhalaya Ltd for the Dec '25 is ₹ 0.25 crore as compare to the Sep '25 ebitda of ₹ 0.26 crore. This represent the decline of -3.85% The ebitda of Kabra Drugs Ltd for the Dec '25 is ₹ 2.62 crore as compare to the Sep '25 ebitda of ₹ 2.22 crore. This represent the growth of 18.02% The net profit of Desh Rakshak Aushdhalaya Ltd changed from ₹ 0.09 crore to ₹ 0.09 crore over 7 quarters. This represents a CAGR of 0.00% The net profit of Kabra Drugs Ltd changed from ₹ -0.55 crore to ₹ 2.57 crore over 7 quarters. This represents a CAGR of NaN% The Dividend Payout of Desh Rakshak Aushdhalaya Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Kabra Drugs Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Desh Rakshak Aushdhalaya Ltd

The flagship company Desh Rakshak Aushdhalaya Limited of Bhagwant Group was originally started in 1901 as a Proprietorship Concern by Late Shri Bhagwant Rai Jain, a well renowned Vaidya Father of Late Dr. Paras Kumar Jain.
The Concern was converted into a Private Limited Company in Jul.'94. Desh Rakshakare the oldest manufacturer of Pure Ayurvedic and Herbal Products as discovered by the Ancient Seers & Sages.
The medicines are categorized into Proprietary & Classical Medicines.
They are currently manufacturing around 450 products (Proprietary & Classical mix) and all of these medicines are manufactured as per the prescribed norms and standards of the Indian Government.
The Company was earlier operating the traditional process of manufacturing ayurvedic medicines. Up to 1976, the company producing ethical products of ayurvedic medicines which were supplied to ayurvedic dispensaries.

About Kabra Drugs Ltd

Kabra Drugs Limited was incorporated as a Limited Company on August 22, 1989.
The Company has set up a Unit at Indore for manufacturing of Ether derivatives which includes Diethyl Ether (Anesthesia), Solvent Ether, Ethyl Chloride Spray (General Anesthesia) and Surgical.
The commercial production commenced in 1991.
Kabra Drugs Limited is the only manufacturer of Ether derivatives in the State of M.P. tHE Company is presently engaged in the business of Permaculture manufacturing and trading in pharma related products.
The Company has 500+ products across India. The Company was incorporated with a mission to enrich the lives through pharmaceutical solutions which are innovative, high-quality and accessible to every family it serves.

FAQs for the comparison of Desh Rakshak Aushdhalaya Ltd and Kabra Drugs Ltd

Which company has a larger market capitalization, Desh Rakshak Aushdhalaya Ltd or Kabra Drugs Ltd?

Market cap of Desh Rakshak Aushdhalaya Ltd is 14 Cr while Market cap of Kabra Drugs Ltd is 62 Cr

What are the key factors driving the stock performance of Desh Rakshak Aushdhalaya Ltd and Kabra Drugs Ltd?

The stock performance of Desh Rakshak Aushdhalaya Ltd and Kabra Drugs Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Desh Rakshak Aushdhalaya Ltd and Kabra Drugs Ltd?

As of May 6, 2026, the Desh Rakshak Aushdhalaya Ltd stock price is INR ₹24.8. On the other hand, Kabra Drugs Ltd stock price is INR ₹26.21.

How do dividend payouts of Desh Rakshak Aushdhalaya Ltd and Kabra Drugs Ltd compare?

To compare the dividend payouts of Desh Rakshak Aushdhalaya Ltd and Kabra Drugs Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.